Skip to content

Evaluation of Eustachian tube status and treatment effect in patients with allergic rhinitis

Evaluation of Eustachian tube status and treatment effect in patients with allergic rhinitis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000029071
Enrollment
Unknown
Registered
2020-01-12
Start date
2019-12-31
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic Rhinitis

Interventions

Allergic Rhinitis Group:mometasone furoate nasal spray, oral antihistamines

Sponsors

Sun Yat-sen Memorial Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: This study randomly selected 60 adult patients with allergic rhinitis from the ENT clinic in Sun Yat-sen Memorial Hospital of Sun Yat-sen University from June 2019 to June 2020, and recruited 60 healthy adult volunteers as the normal control group. The diagnostic criteria refer to the 2015 Tianjin Guidelines for Allergic Rhinitis. Skin test or specific IgE tests are used to identify allergens.

Exclusion criteria

Exclusion criteria: Patients who had used nasal / oral anti-allergic drugs one month before the consultation, as well as patients with sinusitis, chronic rhinitis, and otitis media, should be excluded.

Design outcomes

Primary

MeasureTime frame
seven-item Eustachian Tube Dysfunction Questionnaire;

Secondary

MeasureTime frame
Nasal endoscopic scroes for pharyngeal orifices of eustachian tube;nasal symptom VAS scores;Tympanometry;Eustachian tube pressure;

Countries

China

Contacts

Public ContactYun Ma

Sun Yat-sen Memorial Hospital

mawenwubei@163.com+86 13480200868

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 18, 2026